Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia Lozano

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Oncology and Therapy|February 27, 2026
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain"Virginia Lozano, Julia Llinares, Patrick Halavacek, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2009
The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potentialKatrien O François, Christophe Pannecouque, Joeri Auwerx, et al.
Journal of Ophthalmic Inflammation and Infection|April 13, 2011
Central retinal artery occlusion in Wegener's granulomatosis: a diagnostic dilemmaVirginia Lozano-López, Beatriz Rodríguez-Lozano, María José Losada-Castillo, et al.
Oncology and Therapy|April 7, 2025
Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in SpainCristina Encinas, Virginia Lozano, Patrick Hlavacek, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 16, 2007
Optic disc tomography and perimetry in controls, glaucoma suspects, and early and established glaucomasManuel Gonzalez de la Rosa, Marta Gonzalez-Hernandez, Virginia Lozano-Lopez, et al.
American Journal of Ophthalmology Case Reports|December 21, 2017
Retinal findings in membranoproliferative glomerulonephritisAhmad M Mansour, Luiz H Lima, J Fernando Arevalo, et al.
Health Economics Review|September 5, 2012
Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCsFrancesc Homar, Virginia Lozano, Juan Martínez-Gómez, et al.
International Journal of Ophthalmology|January 30, 2018
Intravitreal dexamethasone implants for diabetic macular edemaAlicia Pareja-Ríos, Paloma Ruiz-de la Fuente-Rodríguez, Sergio Bonaque-González, et al.
Journal of Medicinal Chemistry|July 14, 2011
Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1,3,5-triazines with aromatic amino acidsVirginia Lozano, Leire Aguado, Bart Hoorelbeke, et al.
Retina (Philadelphia, Pa.)|November 30, 2007
Diagnostic and therapeutic challengesVirginia Lozano, Miguel A Serrano, Maria J Losada, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Oncology and Therapy|February 27, 2026
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain"Virginia Lozano, Julia Llinares, Patrick Halavacek, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2009
The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potentialKatrien O François, Christophe Pannecouque, Joeri Auwerx, et al.
Journal of Ophthalmic Inflammation and Infection|April 13, 2011
Central retinal artery occlusion in Wegener's granulomatosis: a diagnostic dilemmaVirginia Lozano-López, Beatriz Rodríguez-Lozano, María José Losada-Castillo, et al.
Oncology and Therapy|April 7, 2025
Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in SpainCristina Encinas, Virginia Lozano, Patrick Hlavacek, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 16, 2007
Optic disc tomography and perimetry in controls, glaucoma suspects, and early and established glaucomasManuel Gonzalez de la Rosa, Marta Gonzalez-Hernandez, Virginia Lozano-Lopez, et al.
American Journal of Ophthalmology Case Reports|December 21, 2017
Retinal findings in membranoproliferative glomerulonephritisAhmad M Mansour, Luiz H Lima, J Fernando Arevalo, et al.
Health Economics Review|September 5, 2012
Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCsFrancesc Homar, Virginia Lozano, Juan Martínez-Gómez, et al.
International Journal of Ophthalmology|January 30, 2018
Intravitreal dexamethasone implants for diabetic macular edemaAlicia Pareja-Ríos, Paloma Ruiz-de la Fuente-Rodríguez, Sergio Bonaque-González, et al.
Journal of Medicinal Chemistry|July 14, 2011
Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1,3,5-triazines with aromatic amino acidsVirginia Lozano, Leire Aguado, Bart Hoorelbeke, et al.
Retina (Philadelphia, Pa.)|November 30, 2007
Diagnostic and therapeutic challengesVirginia Lozano, Miguel A Serrano, Maria J Losada, et al.
Pageof 3